Use of saralasin in end-stage renal disease.
D000328:Adult; D000804:Angiotensin II / Q000031:analogs & derivatives* / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D001810:Blood Volume; D005260:Female; D006801:Humans; D006977:Hypertension, Renal / Q000175:diagnosis*; D006978:Hypertension, Renovascular / Q000175:diagnosis* / Q000209:etiology; D007263:Infusions, Parenteral; D007676:Kidney Failure, Chronic / Q000150:complications / Q000378:metabolism / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy; D006435:Renal Dialysis; D012083:Renin / Q000097:blood; D012504:Saralasin / Q000378:metabolism
D000804:Angiotensin II; D012083:Renin; D012504:Saralasin